$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
Instructions for Pazopanib manufacturers and regular purchasing channels
2026-02-01 22:25:32
Check Details
Latest news and clinical research progress summary of Opicapone
2026-02-01 22:25:32
Check Details
How many pills of Fenelidone (Kesenda) are safest and best to take a day?
2026-02-01 22:25:32
Check Details
Analysis of the biggest advantages and clinical use value of rasagiline (Azila)
2026-02-01 22:25:32
Check Details
The latest price trends of Lemborexant and analysis of price differences in domestic and foreign markets
2026-02-01 22:25:32
Check Details
Which company produces Mavakatai (Maifantuo) and a detailed introduction to its research and development background?
2026-02-01 22:25:32
Check Details
Does tenofovir alafenamide fumarate tablets (Vemlidy) need to be taken for life and the risk of discontinuation?
2026-02-01 22:25:32
Check Details
The domestic market price and purchasing methods of vorasidenib-VORANIGO
2026-02-01 22:25:32
Check Details
Precautions and safety tips when using eflornithine (IWILFIN)
2026-02-01 22:25:32
Check Details
Detailed introduction and clinical treatment application scope of Odyxibat (Beierwei)
2026-02-01 22:25:32
Check Details
Detailed explanation of common side effects of Donepezil (Aricept) and how to deal with them
2026-02-01 22:25:32
Check Details
Is Fidaxomicin currently available in the country and the official channels?
2026-02-01 22:25:32
Check Details
1
2
...
1918
1919
1920
1921
1922
1923
1924
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma